- Home
- RPTX vs VNRX Comparison
RPTX vs VNRX Comparison
Compare RPTX & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- VNRX
- Stock Information
- Founded
- RPTX 2016
- VNRX N/A
- Country
- RPTX Canada
- VNRX United States
- Employees
- RPTX N/A
- VNRX N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RPTX Health Care
- VNRX Health Care
- Exchange
- RPTX Nasdaq
- VNRX Nasdaq
- Market Cap
- RPTX 53.2M
- VNRX 45.2M
- IPO Year
- RPTX 2020
- VNRX N/A
- Fundamental
- Price
- RPTX $0.93
- VNRX $0.51
- Analyst Decision
- RPTX Strong Buy
- VNRX Strong Buy
- Analyst Count
- RPTX 3
- VNRX 5
- Target Price
- RPTX $4.50
- VNRX $3.75
- AVG Volume (30 Days)
- RPTX 266.1K
- VNRX 278.1K
- Earning Date
- RPTX 05-06-2025
- VNRX 05-12-2025
- Dividend Yield
- RPTX N/A
- VNRX N/A
- EPS Growth
- RPTX N/A
- VNRX N/A
- EPS
- RPTX N/A
- VNRX N/A
- Revenue
- RPTX $53,477,000.00
- VNRX $1,233,511.00
- Revenue This Year
- RPTX N/A
- VNRX $812.84
- Revenue Next Year
- RPTX $2.61
- VNRX $162.93
- P/E Ratio
- RPTX N/A
- VNRX N/A
- Revenue Growth
- RPTX 4.58
- VNRX 59.10
- 52 Week Low
- RPTX $0.89
- VNRX $0.42
- 52 Week High
- RPTX $4.29
- VNRX $1.02
- Technical
- Relative Strength Index (RSI)
- RPTX 34.51
- VNRX 45.73
- Support Level
- RPTX $0.89
- VNRX $0.45
- Resistance Level
- RPTX $1.02
- VNRX $0.63
- Average True Range (ATR)
- RPTX 0.07
- VNRX 0.07
- MACD
- RPTX -0.01
- VNRX -0.00
- Stochastic Oscillator
- RPTX 19.10
- VNRX 43.38
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.